Tema ETFs’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
WAP
SFA
MFG
IFG
WCP
TWD
FFA
GI
Tema ETFs's CMPX Position: Q2 2026 in Review
Tema ETFs sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 138,276 shares — an estimated $731K sold.
Tema ETFs first reported a position in CMPX in Q4 2025 and held it in 2 quarters. The position peaked at $731K in Q1 2026. 9 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.
- Tema ETFs reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
- Tema ETFs sold 138,276 Compass Therapeutics shares in Q2 2026, an estimated $731K.
- Tema ETFs first reported a position in Compass Therapeutics in Q4 2025 and held it in 2 quarters.
- Tema ETFs's Compass Therapeutics position peaked at $731K in Q1 2026.
- 9 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.
Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.